ProQR Therapeutics N.V. Forecast and Stock Analysis
Technical PRQR stock analysis for February 15, 2019.
ProQR Therapeutics N.V. fell by -1.41% in the last day from $14.20 to $14.00 and has now fallen 4 days in a row. The price has fallen in 7 of the last 10 days and is down by -16.02% for this period. Volume has increased in the last day by 40 272 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 153 978 shares bought and sold for approximately $2.16 million.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the PRQR stock was $14.00. This is 1.41% less than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 4.86% from a day low at $13.78 to a day high of $14.45.
30 day high of the PRQR stock price was $16.99 and low was $13.78.
90 day high was $21.00 and low was $13.78.
52 week high for the ProQR Therapeutics N.V. - $24.00 and low - $2.90.
ProQR Therapeutics N.V. lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -23.60% during the next 3 months and, with 90% probability hold a price between $9.37 and $12.29 at the end of this period.
There are few to none technical positive signals at the moment. ProQR Therapeutics N.V. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $14.73 and $15.56. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Monday February 04, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSI14 is 44 and the stock is currently not being overbought or oversold
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.67 between high and low, or 4.86%. For the last week, the stock has had a daily average volatility of 4.80%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
ProQR Therapeutics N.V. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.